Cargando…
Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer
KRAS is the most commonly mutated oncogene in NSCLC and development of direct KRAS inhibitors has renewed interest in this molecular variant. Different KRAS mutations may represent a unique biologic context with different prognostic and therapeutic impact. We sought to characterize genomic landscape...
Autores principales: | Judd, Julia, Abdel Karim, Nagla, Khan, Hina, Naqash, Abdul Rafeh, Baca, Yasmine, Xiu, Joanne, VanderWalde, Ari M., Mamdani, Hirva, Raez, Luis E., Nagasaka, Misako, Pai, Sachin Gopalkrishna, Socinski, Mark A., Nieva, Jorge J., Kim, Chul, Wozniak, Antoinette J., Ikpeazu, Chukwuemeka, de Lima Lopes, Gilberto, Spira, Alexander I., Korn, W. Michael, Kim, Edward S., Liu, Stephen V., Borghaei, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662933/ https://www.ncbi.nlm.nih.gov/pubmed/34518295 http://dx.doi.org/10.1158/1535-7163.MCT-21-0201 |
Ejemplares similares
-
HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study
por: Osada, Takuya, et al.
Publicado: (2022) -
Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible
por: Jensen, Taylor J., et al.
Publicado: (2021) -
Monitoring Circulating Tumor DNA During Surgical Treatment in Patients with Gastrointestinal Stromal Tumors
por: Johansson, Gustav, et al.
Publicado: (2021) -
Reverse Translating Molecular Determinants of Anti–Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor Models
por: Georgiev, Peter, et al.
Publicado: (2022) -
A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas
por: Shah, Avanthi Tayi, et al.
Publicado: (2021)